[1] |
O′Neal WT, Soliman EZ, Howard G,et al. Inflammation and hemostasis in atrial fibrillation and coronary heart disease:The REasons for Geographic And Racial Differences in Stroke study[J]. Atherosclerosis,2015,243(1):192-197.
|
[2] |
Jarvie JL, Whooley MA, Regan MC,et al. Effect of physical activity level on biomarkers of inflammation and insulin resistance over 5 years in outpatients with coronary heart disease (from the Heart and Soul Study)[J]. Am J Cardiol,2014,114(8):1192-1197.
|
[3] |
von Känel R, Carney RM, Zhao S,et al. Heart rate variability and biomarkers of systemic inflammation in patients with stable coronary heart disease:findings from the Heart and Soul Study[J]. Clin Res Cardiol,2011,100(3):241-247.
|
[4] |
Golub LM, Elburki MS, Walker C,et al. Non-antibacterial tetracycline formulations:host-modulators in the treatment of periodontitis and relevant systemic diseases[J]. Int Dent J,2016,66(3):127-135.
|
[5] |
Persson GR, Persson RE. Cardiovascular disease and periodontitis:an update on the associations and risk[J]. J Clin Periodontol,2008,35(8 Suppl):362-379.
|
[6] |
Murakami T. Understanding and treatment strategy of the pathogenesis of periodontal disease based on chronic inflammation[J]. Clin Calcium,2016,26(5):766-772.
|
[7] |
Dietrich T, Sharma P, Walter C,et al. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease[J]. J Periodontol,2013,84(4 Suppl):S70-S84.
|
[8] |
Beck JD, Couper DJ, Falkner KL,et al. The Periodontitis and Vascular Events(PAVE)pilot study:adverse events[J]. J Periodontol,2008,79(1):90-96.
|
[9] |
Firoz CK, Jabir NR, Kamal MA,et al. Neopterin:An immune biomarker of coronary artery disease and its association with other CAD markers[J]. IUBMB Life,2015,67(6):453-459.
|
[10] |
Signorelli SS, Anzaldi M, Fiore V,et al. Neopterin:a potential marker in chronic peripheral arterial disease[J]. Mol Med Rep,2013,7(6):1855-1858.
|
[11] |
Ray KK, Morrow DA, Sabatine MS,et al. Long-term prognostic value of neopterin:a novel marker of monocyte activation in patients with acute coronary syndrome[J]. Circulation,2007,115(24):3071-3078.
|
[12] |
Vengen IT, Dale AC, Wiseth R,et al. Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus long-term follow-up of the HUNT 1 study[J]. Atherosclerosis,2009,207(1):239-244.
|
[13] |
Mahendra L, Mahendra J, Borra SK,et al. Estimation of salivary neopterin in chronic periodontitis[J]. Indian J Dent Res,2014,25(6):794-796.
|
[14] |
Tonetti MS. Periodontitis and risk for atherosclerosis:an update on intervention trials[J]. J Clin Periodontol,2009,36(Suppl 10):15-19.
|
[15] |
Lee DH, Youn HJ, Choi YS,et al. Coronary flow reserve is a comprehensive indicator of cardiovascular risk factors in subjects with chest pain and normal coronary angiogram[J]. Circ J,2010,74(7):1405-1414.
|
[16] |
Pawlak K, Mysliwiec M, Pawlak D. Endocan—the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease[J]. Clin Biochem,2015,48(6):425-430.
|
[17] |
Arsenault BJ, Rana JS, Stroes ES,et al. Beyond low-density lipoprotein cholesterol:respective contributions of non-high-density lipoprotein cholesterol levels,triglycerides,and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women[J]. J Am Coll Cardiol,2009,55(1):35-41.
|
[18] |
龚平,李莎,胡良焱,等. ABO血型与冠心病及血脂的相关性[J].中华心血管病杂志,2015,43(5):404-407.
|
[19] |
Jung YS, Shin MH, Kim IS,et al. Relationship between periodontal disease and subclinical atherosclerosis:the Dong-gu study[J]. J Clin Periodontol,2014,41(3):262-268.
|
[20] |
Machado WM, Prestes AP, Costa TP,et al. The effect of simvastatin on systemic inflammation and endothelial dysfunction induced by periodontitis[J]. J Periodontal Res,2014,49(5):634-641.
|
[21] |
Yang J, Feng L, Ren J,et al. Correlation between the severity of peridontitis and the coronary artery stenosis in a Chinese population[J]. Aust Dent J,2013,58(3):333-338.
|
[22] |
冯磊,杨军英,任静,等.冠心病患者牙周炎严重程度对血清超敏C反应蛋白和TNF-α及冠脉狭窄程度的影响[J].中山大学学报(医学科学版),2012,33(6):797-802.
|
[23] |
任静,杨军英,陶军,等.牙周非手术治疗对动脉硬度和血清sICAM-1的影响[J].中山大学学报(医学科学版),2016,37(1):66-70,76.
|
[24] |
Liu ZY, Li YD. Relationship between serum neopterin levels and coronary heart disease[J]. Genet Mol Res,2013,12(4):4222-4229.
|
[25] |
Gurumurthy P, Borra SK, Yeruva RK,et al. Estimation of serum neopterin in patients with acute coronary syndrome[J]. Asian Cardiovasc Thorac Ann,2013,21(4):426-431.
|
[26] |
Chomyszyn-Gajewska M. Evaluation of chosen salivary periodontal disease markers[J]. Przegl Lek,2010,67(3):213-216.
|
[27] |
Pradeep AR, Kumar MS, Ramachandraprasad MV,et al. Gingival crevicular fluid levels of neopterin in healthy subjects and in patients with different periodontal diseases[J]. J Periodontol,2007,78(10):1962-1967.
|
[28] |
Abdel-Haq A, Kusnierz-Cabala B, Darczuk D,et al. Interleukin-6 and neopterin levels in the serum and saliva of patients with Lichen planus and oral Lichen planus[J]. J Oral Pathol Med,2014,43(10):734-739.
|
[29] |
Moutereau S, Ech Chad N, Devanlay M,et al. Improved neopterin ELISA kit:a good compromise between HPLC results and clinical practice[J]. Clin Chem Lab Med,2011,49(3):553-554.
|
[30] |
陈松劲,金松华,杨晓朝,等.酶联免疫吸附试验检测新蝶呤的方法学评价[J].中华医院感染学杂志,2009,19(20):2816-2818.
|
[31] |
Bakhtadze MG, Margvelashvili VV, Kamkamidze GK,et al. Interferon-gamma and neopterin in blood serum of patients with chronic periodontitis[J]. Georgian Med News,2006(132):30-33.
|